Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

235.05
BATS BZX Real-Time Price
As of 10:23am ET
 -0.24 / -0.10%
Today’s Change
184.50
Today|||52-Week Range
281.28
+11.92%
Year-to-Date
All Eyes On Washington: US Futures Rise On Hope Healthcare Vote Will Pass
7:20am / Investing Channel - Paid Partner Content
Adding to AGN Long
Mar 23 / TheStreet.com - Paid Partner Content
The Most Attractive Value Stock There Is?
Mar 23 / GuruFocus News - Paid Partner Content
Allergan's Restasis Now Available in Multidose Bottle in U.S.
Mar 23 / Zacks.com - Paid Partner Content
The Good, the Bad and the Ugly (Early Afternoon Edition)
Mar 23 / TheStreet.com - Paid Partner Content
Companies Spend Less on Share Buybacks for Second Year in 2016
Mar 23 / GuruFocus News - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 23 / GuruFocus News - Paid Partner Content
Corporate Share Repurchases Decline for 2nd Year in a Row
Mar 22 / GuruFocus News - Paid Partner Content
AstraZeneca Stock Rising in '17: What's Working in its Favor?
Mar 23 / Zacks.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 21 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close235.29
Today’s open235.35
Day’s range235.01 - 236.01
Volume12,398
Average volume (3 months)4,211,810
Market cap$78.9B
Dividend yield1.19%
Data as of 10:23am ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.81%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.12-0.38%
ABTAbbott Laboratories+0.17+0.38%
NVONovo Nordisk+0.64+1.93%
LLYEli Lilly and Co-0.05-0.06%
Data as of 10:25am ET, 03/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.39
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs